Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Asymptomatic Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03236428
What this trial is testing

Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma

Who this might be right for
Monoclonal GammopathySmoldering Multiple Myeloma
Dana-Farber Cancer Institute 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT03673826
What this trial is testing

Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM

Who this might be right for
Smouldering Myeloma
Stichting Hemato-Oncologie voor Volwassenen Nederland 58
Early research (Phase 1)Study completedNCT02492750
What this trial is testing

Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma

Who this might be right for
Indolent Plasma Cell MyelomaPlasma Cell MyelomaSmoldering Plasma Cell Myeloma
Mayo Clinic 14
Testing effectiveness (Phase 2)WithdrawnNCT01571726
What this trial is testing

Imaging Studies and the Development of Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06100237
What this trial is testing

Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)

Who this might be right for
Multiple Myeloma
Carl Ola Landgren, MD, PhD 50
Testing effectiveness (Phase 2)WithdrawnNCT01660997
What this trial is testing

MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT02269592
What this trial is testing

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Myelodysplastic SyndromesHematological Malignancies+5 more
Dana-Farber Cancer Institute 10,000
Testing effectiveness (Phase 2)Study completedNCT01463670
What this trial is testing

Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT05014646
What this trial is testing

Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients

Who this might be right for
Smoldering Plasma Cell Myeloma
City of Hope Medical Center 27
Not applicableLooking for participantsNCT06644625
What this trial is testing

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

Who this might be right for
Multiple MyelomaMultiple Myeloma ProgressionMonoclonal Gammopathy of Undetermined Significance (MGUS)+2 more
Wake Forest University Health Sciences 1,665
Testing effectiveness (Phase 2)Study completedNCT03792763
What this trial is testing

Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients

Who this might be right for
Multiple Myeloma
Arbeitsgemeinschaft medikamentoese Tumortherapie 8
Testing effectiveness (Phase 2)Study completedNCT03839459
What this trial is testing

Denosumab for Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
University of Rochester 20
Testing effectiveness (Phase 2)Looking for participantsNCT06762769
What this trial is testing

Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma

Who this might be right for
Smouldering Myeloma
University College, London 63
Early research (Phase 1)UnknownNCT02240537
What this trial is testing

Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer

Who this might be right for
Acute Myelogenous Leukemia (AML)Multiple Myeloma (MM)Myelodysplastic Syndrome (MDS)+1 more
Benovus Bio, Inc. 4
Not applicableActive Not RecruitingNCT04144387
What this trial is testing

Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations.

Who this might be right for
Smoldering Multiple Myeloma
Intergroupe Francophone du Myelome 395
Testing effectiveness (Phase 2)Study completedNCT01222286
What this trial is testing

Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Innate Pharma 30
Testing effectiveness (Phase 2)Looking for participantsNCT06574126
What this trial is testing

Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma

Who this might be right for
High Risk Smoldering Multiple Myeloma
PETHEMA Foundation 20
Large-scale testing (Phase 3)Looking for participantsNCT03937635
What this trial is testing

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
ECOG-ACRIN Cancer Research Group 288
Testing effectiveness (Phase 2)WithdrawnNCT03952832
What this trial is testing

Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
City of Hope Medical Center
Not applicableLooking for participantsNCT03717844
What this trial is testing

Registry for Adults With Plasma Cell Disorders (PCD's)

Who this might be right for
Multiple MyelomaAmyloidosisCryoglobulinemia+6 more
UNC Lineberger Comprehensive Cancer Center 2,000
Next Page